Evaluation of the effect of inhaled budesonide (Pulmicort) on children with acute asthma attack
Phase 3
Recruiting
- Conditions
- Acute asthma attack in pediatric.Asthma
- Registration Number
- IRCT20190106042260N2
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Diagnosed as asthma by doctor
Lack of other chronic and specific diseases
Diagnosis as acute asthma attack by doctor
Age range Between 2-12 years old
Exclusion Criteria
A child with heart disease
Lack of willingness to participate in the study
Have chronic lung disease other than asthma
Children who have received specific steroid medications over the past 7 days
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cough rate. Timepoint: 6,12,24,48 hours after the interventions. Method of measurement: Based on mild / moderate / severe.;Weezing score. Timepoint: 6,12,24,48 hours after the interventions. Method of measurement: Based on a score of 0 to 3/ without, in inhalation, in exhalation, Both.;Workup Breathing. Timepoint: 6,12,24,48 hours after the interventions. Method of measurement: Based on mild / moderate / severe.;Duration of hospitalization. Timepoint: The number of hospitalization days. Method of measurement: According to the number of days.;Respiratory rate. Timepoint: 6,12,24,48 hours after the interventions. Method of measurement: Based on mild / moderate / severe.;Possible complication. Timepoint: During the hospitalisation. Method of measurement: Based on drug side effects.
- Secondary Outcome Measures
Name Time Method